Additionally, glioma cells harboring IDH1 mutations demonstrate increased sensitivity to glutaminase inhibition, suggesting that glutaminolysis serves as a compensatory mechanism essential for maintaining metabolic homeostasis [36]. This evidence concerns the gene IDH1 and central nervous system cancer.